New Stock Alert | Xinji Pharmaceutical, Yifei Technology Among Companies With Hong Kong IPO Applications Accepted by China Securities Regulatory Commission

Stock News

01/30

According to information obtained by Zhitong Caijing APP, on January 30, the China Securities Regulatory Commission (CSRC) released the "Status Table for Overseas Securities Issuance and Listing by Domestic Enterprises (Initial Public Offerings and Full Circulation) (As of January 30, 2026)." The table indicates that the CSRC has received application materials for Hong Kong IPOs from Xinji Pharmaceutical, Yifei Technology, Daoyuan Technology, Chelian Tianxia, Weimai Medical, Jingwang Electronics, Junce Biotech, and Zhuxian Technology. Separately, the filing status for Lao Xiang Ji's (indirect overseas listing) proposed Hong Kong IPO has moved to the "soliciting opinions" stage. Meanwhile, the filing status for Xinmai Semiconductor's intended Hong Kong IPO is listed as "supplementing materials."

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/news/1186833842"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1186833842\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1186833842?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-01-30 20:34","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1186833842","market":"sg","top_or_hot":-1,"title":"New Stock Alert | Xinji Pharmaceutical, Yifei Technology Among Companies With Hong Kong IPO Applications Accepted by China Securities Regulatory Commission","media":"Stock News","content":"<p>According to information obtained by Zhitong Caijing APP, on January 30, the China Securities Regulatory Commission (CSRC) released the \"Status Table for Overseas Securities Issuance and Listing by Domestic Enterprises (Initial Public Offerings and Full Circulation) (As of January 30, 2026).\" The table indicates that the CSRC has received application materials for Hong Kong IPOs from Xinji Pharmaceutical, Yifei Technology, Daoyuan Technology, Chelian Tianxia, Weimai Medical, Jingwang Electronics, Junce Biotech, and Zhuxian Technology. Separately, the filing status for Lao Xiang Ji's (indirect overseas listing) proposed Hong Kong IPO has moved to the \"soliciting opinions\" stage. Meanwhile, the filing status for Xinmai Semiconductor's intended Hong Kong IPO is listed as \"supplementing materials.\"</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>New Stock Alert | Xinji Pharmaceutical, Yifei Technology Among Companies With Hong Kong IPO Applications Accepted by China Securities Regulatory Commission</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nNew Stock Alert | Xinji Pharmaceutical, Yifei Technology Among Companies With Hong Kong IPO Applications Accepted by China Securities Regulatory Commission\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036600163\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock News </p>\n<p class=\"h-time smaller\">2026-01-30 20:34</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>According to information obtained by Zhitong Caijing APP, on January 30, the China Securities Regulatory Commission (CSRC) released the \"Status Table for Overseas Securities Issuance and Listing by Domestic Enterprises (Initial Public Offerings and Full Circulation) (As of January 30, 2026).\" The table indicates that the CSRC has received application materials for Hong Kong IPOs from Xinji Pharmaceutical, Yifei Technology, Daoyuan Technology, Chelian Tianxia, Weimai Medical, Jingwang Electronics, Junce Biotech, and Zhuxian Technology. Separately, the filing status for Lao Xiang Ji's (indirect overseas listing) proposed Hong Kong IPO has moved to the \"soliciting opinions\" stage. Meanwhile, the filing status for Xinmai Semiconductor's intended Hong Kong IPO is listed as \"supplementing materials.\"</p>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"159938","symbol_name":"醫藥","start_time":0,"source_url":"","article_id":"1186833842","we_media_id":"1036600163","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1186833842","pubTimestamp":1769776456,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Stock News","introduction":"Global Stock News First-Time Broadcast","home_visible":1,"id":"1036600163","head_image":"https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a"},"summary":"According to information obtained by Zhitong Caijing APP, on January 30, the China Securities Regulatory Commission (CSRC) released the \"Status Table for Overseas Securities Issuance and Listing by...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"159938":"医药","BK1515":"抗疫概念","BK1161":"生物科技","BK1574":"生物医药B类股","02565":"派格生物医药-B","09939":"开拓药业-B"},"translate_title":"新股快讯|香港IPO申请获证监会受理企业中的新济药业、逸飞科技","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"159938":1,"02565":1,"09939":1},"content_text":"According to information obtained by Zhitong Caijing APP, on January 30, the China Securities Regulatory Commission (CSRC) released the \"Status Table for Overseas Securities Issuance and Listing by Domestic Enterprises (Initial Public Offerings and Full Circulation) (As of January 30, 2026).\" The table indicates that the CSRC has received application materials for Hong Kong IPOs from Xinji Pharmaceutical, Yifei Technology, Daoyuan Technology, Chelian Tianxia, Weimai Medical, Jingwang Electronics, Junce Biotech, and Zhuxian Technology. Separately, the filing status for Lao Xiang Ji's (indirect overseas listing) proposed Hong Kong IPO has moved to the \"soliciting opinions\" stage. Meanwhile, the filing status for Xinmai Semiconductor's intended Hong Kong IPO is listed as \"supplementing materials.\"","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}